Billerica, MA – BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the availability of the new BD Falcon™ Multi-Flask, a multi-layer cell culture device that will allow researchers to scale-up their cell culture easily and more efficiently. Currently, most expansion of attachment-dependent cells occurs in single-layer flasks. The new BD Falcon […]
EDMONTON – Compass Biotechnologies (COBI:OB) is a product-oriented specialty biotechnology company focused on offering products for multi-billion dollar markets. The company is pleased to announce it has entered into an expanded relationship with PanGen Biotech of South Korea, which will allow Compass to offer a globally marketed comprehensive laboratory reagents product line for sale under […]
NEW YORK, NY – IntelliCell BioSciences, Inc., a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose-derived adult stem cells, announced today that it has executed an exclusive supply and sale agreement with Millipore Corporation, a global leader in innovative tools and technologies for bio-manufacturing and life science research, to […]
PARIS — CYTOO, a company that specializes in cell-based assays (Grenoble, France), has joined up with Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS), and the CEA, the French Alternative Energies and Atomic Energy Commission, to develop new high-value cell-based assays for drug development and toxicology. The project, named […]
CARDIFF, Wales– Kay Swinburne, MEP visited GE Healthcare’s Maynard Centre in Cardiff, Wales on Friday 23rd September. The Maynard Centre, operational since 1980 and with approximately 450 employees, is a key research and manufacturing facility for GE Healthcare’s Life Sciences business. During her visit, Dr. Swinburne met with GE Healthcare scientists who are developing new, […]
SOUTH SAN FRANCISCO, Calif.–Fluxion Biosciences, Inc. announced today that it has launched an Early Access Program for its IsoFlux Rare Cell Access System. The program will enable scientists to incorporate circulating tumor cells (CTC) and other rare cell assays into their research prior to the IsoFlux commercial product release. Circulating tumor cells disseminate from primary […]
nanoTherics, a UK-based scientific medical research devices company, is pleased to announce launch of the magnefect-nano II™. This new, compact device offers gene transfection with improved efficiencies and cell viabilities, even with a range of difficult cell types such as neuronal and primary cells. It uses a unique technology applying proprietary magnet configurations and oscillating […]
GOTHENBURG, Sweden – Cellectricon appoints David Burns as the company’s Chief Executive Officer. David brings a solid and highly impressive international Life Science executive track record to Cellectricon vital for the company’s continued market expansion in bringing state-of-the-art screening solutions for drug discovery and cell-based research. David Burns has extensive experience of the life sciences […]
SAN DIEGO — Silicon Biosystems, Inc., a provider of specialized molecular and cellular biology technology, announced today its entry with Fox Chase Cancer Center in Philadelphia, PA, into an agreement for the company’s DEPArray(TM) technology. Fox Chase Cancer Center is a leading research institute in the field of metastatic cancers and has been a champion […]
MADISON, Wis. – Cellular Dynamics International (CDI) today announced the commercial launch of human iCell® Endothelial Cells for use in vascular-targeted drug discovery, tissue regeneration and other life science research. Endothelial cells make up the lining of blood vessels and thus are an important factor of vascular research across a multitude of disease states. Endothelial […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
